We’re rated Excellent
4.7 out of 5 based on 100 reviews

Human Rights Day Reading Dec 10

Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform

Gene therapy goes acoustic as ARCH-backed biotech launches with ultrasound gene delivery platform – Endpoints News (endpts.com)

Nkarta underscores safety of CAR-NK, boasts early responses

Nkarta underscores safety of CAR-NK, boasts early responses – Endpoints News (endpts.com)

The Era of One-Shot, Multimillion-Dollar Genetic Cures Is Here

Gene therapies promise long-term relief from intractable diseases—if insurers agree to pony up.

The Era of One-Shot, Multimillion-Dollar Genetic Cures Is Here | WIRED

Abandoned - The human cost of neurotechnology failure

When the makers of electronic implants abandon their projects, people who rely on the devices have everything to lose.

Abandoned: the human cost of neurotechnology failure (nature.com)

BioCardia's off-the-shelf cell therapy for heart failure to enter first-in-human study

BioCardia's off-the-shelf cell therapy for heart failure to enter first-in-human study (fiercebiotech.com)

DeepMind AI topples experts at complex game Stratego

Game-playing AIs that interact with humans are laying important groundwork for real-world applications.

DeepMind AI topples experts at complex game Stratego (nature.com)

Researchers welcome $3.5-million haemophilia gene therapy — but questions remain

The world’s most expensive drug has the potential to save lives. But it cannot treat the most common form of the disease.

Researchers welcome $3.5-million haemophilia gene therapy — but questions remain (nature.com)

What Causes Alzheimer’s? Scientists Are Rethinking the Answer.

After decades in the shadow of the reigning model for Alzheimer’s disease, alternative explanations are finally getting the attention they deserve.

What Causes Alzheimer’s? Scientists Are Rethinking the Answer. | Quanta Magazine

The therapeutic potential of psychedelics

The development of psychedelics as medicines faces several challenges

The therapeutic potential of psychedelics | Science

Decoding CAR T cell phenotype using combinatorial signalling motif libraries and machine learning

Decoding CAR T cell phenotype using combinatorial signalling motif libraries and machine learning | Science

Gilead buys into multiple myeloma cell therapy with Arcellx deal

Gilead buys into multiple myeloma cell therapy with Arcellx deal | BioPharma Dive